Grant - Unravel Biosciences

Grant - Unravel Biosciences

Investment Firm

Overview

The first rapid prototyping therapeutics company

Announced Date

Mar 29, 2023

Funding Type

Grant

Highlights

Location

United States, North America

Social

Investor Lead

Massachusetts General Hospital

Massachusetts General Hospital

No designation

Participant Investors

1

Investor Name
Participant InvestorMassachusetts General Hospital

Round Details and Background

Unravel Biosciences raised $550000 on 2023-03-29 in Grant

The first rapid prototyping therapeutics company

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 01, 2021
Grant - Unravel Biosciences
-330.0K
Oct 10, 2021
Pre Seed Round - Unravel Biosciences
4-1.6M
Mar 29, 2023
Grant - Unravel Biosciences
1-550.0K
Feb 20, 2023
Pre Seed Round - Unravel Biosciences
-750.0K

Recent Activity

There is no recent news or activity for this profile.